This weblog will focus on issues at the intersection of patent law and FDA law. For example, I aim to discuss drug development and patenting; Hatch-Waxman litigation; and antitrust issues in pharmaceutical patent cases. I am a patent lawyer, and therefore I will be looking at these topics from that perspective. Others, such as those more involved in regulatory issues, may bring different perspectives; comments on posts are always welcome. Thank you for visiting. And thanks to Dennis Crouch for inspiring me to start a blog and for his assistance setting it up.
Recent Posts
- Hikma v. Vanda: Oral Argument Recap
- Teva v. Lilly should not be read as creating a new 112 rule for method of use claims
- Should ANDA filers be using the PTAB to mount early challenges to OB patents?
- Switching to WordPress
- Judge Hughes concurrence highlights post grant review appeal standing issue for pharma cases
Posted in Uncategorized
One response to “Welcome to Orange Book Blog!”
-
I was delighted to learn of the Orange Book Blog and hope to participate in the future! Best regards, Jay Thomas, Georgetown University Law Center
LikeLike

Leave a comment